Tohru Nagamitsu

1 Patent

• US126053592026

  Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Inhibitor and Pharmaceutical Use Therefor

  LIPOPROTEIN RESEARCH STOCKHOLM AB

  0 cites